Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Plandai Biotechnology’s SORBEO Phytofare Reports Positive Results in Chicken Studies
May 30, 2018 08:00 ET
|
Plandai Biotechnology, Inc.
Addresses the Worldwide Poultry Industry for Feed Additive in Chicken Diets LONDON, UNITED KINGDOM, May 30, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology, Inc. (OTC Markets: PLPL) (the...
Plandai Biotechnology Announces Origine 8 Wins Prestigious Natural & Organic Products Award
May 24, 2018 10:30 ET
|
Plandai Biotechnology, Inc.
Phytofare® Based Nutriceutical Wins Judges Choice for 2018 LONDON, UK, May 24, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology, Inc. (PLPL) (“Plandai” or “the Company”), producer of the...
Plandai Biotechnology Issues Business Targets and Milestones for Remainder of 2018
March 20, 2018 08:30 ET
|
Plandai Biotechnology, Inc.
Looking to Ramp Commercialization and Accelerate Revenue Growth LONDON, UNITED KINGDOM, March 20, 2018 (GLOBE NEWSWIRE) -- Plandaí Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or...
Plandaí Biotechnology's Upcoming Clinical Trial Could Strengthen Case for Phytofare in Treatment of Diabetes
May 18, 2017 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 18, 2017) - Plandaí Biotechnology (OTCQB: PLPL) announced that it will conduct a human clinical trial to study the effectiveness of using its highly bioavailable...
Plandaí Biotechnology Changing the Future of Green Tea with Technology Used in Origine 8 Capsules
May 10, 2017 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 10, 2017) - Plandaí Biotechnology's (OTCQB: PLPL) Origine 8™ capsules could be the future of green tea. Drinking a cup of green tea tastes great, but unless the eight...
Plandai Biotechnology Expanding Footprint of Phytofare into U.S. with Continued Sales
May 04, 2017 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 04, 2017) - Plandaí Biotechnology (OTCQB: PLPL) announced last week that its highly bioavailable Phytofare® Catechin Complex would be the active ingredient in Capital...
Plandai Biotechnology Gains Credibility with NutriBullet Deal
April 26, 2017 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - April 26, 2017) - Plandaí Biotechnology (OTCQB: PLPL) expects Capital Brands, LLC, the developer, marketer, and distributor of both the wildly popular NutriBullet and...
Plandai Biotechnology Sets Aggressive Agenda for 2017
April 19, 2017 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - April 19, 2017) - Plandaí Biotechnology (OTCQB: PLPL) recently presented investors with its outlook for 2017 and a number of milestones that the company plans to...
Plandai Biotechnology, Inc. Announces Expansion of Agreement With USN to Now Include the European Union
August 10, 2015 09:00 ET
|
Plandai Biotechnology, Inc.
GOODYEAR, AZ--(Marketwired - August 10, 2015) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) (“Plandaí" or “the Company”), producer of the highly bioavailable Phytofare® catechin complex, today announced...
Plandai Biotechnology, Inc. Continues to Deliver Green Tea Extract to USN
July 13, 2015 09:00 ET
|
Plandai Biotechnology, Inc.
GOODYEAR, AZ--(Marketwired - July 13, 2015) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) (“Plandaí” or “the Company”), producer of the highly bioavailable Phytofare® Catechin Complex, today announced...